Mdm2 plays a very crucial role in the regulation of p53 stability and p53-induction in response to DNA damage. The binding of Mdm2 to p53 is required for targeting p53 for degradation. p73, however, binds to Mdm2 but is resistant to degradation by Mdm2 and to the induction by DNA damage, indicating that binding to Mdm2 is not sufficient for degradation and there must be a sequence unique to p53 that determines its response to Mdm2-mediated degradation and to DNA damage. By utilizing the structural homology between p53 and p73, we generated p53-p73 chimeras, where each of p53 domains was replaced by the corresponding region of p73, to determine the sequence element of p53 essential for regulation of its stability. We found that replacing the amino acid 92-112 of p53 abolishes its ability to respond to Mdm2-mediated degradation and to the induction by damage. Significantly, the finding that swapping this fragment converts p73 from refractory into sensitive to Mdm2-mediated degradation and induction by DNA damage supports that the amino acid 92-112 of p53 is an essential element in the regulation of its stability and response to DNA damage. Preliminary studies also provide compelling evidences to indicate a presence of additional protein(s) that associates with the element and is essential for Mdm2-mediated degradation. This proposal aims at identifying the protein(s) and investigating its role in Mdm2-mediated degradation and in DNA damage-induced p53 accumulation. Potential involvement of the p53 determinant in the regulation of p53 nuclear import/export will also be examined. Results obtained from the proposed work will likely provide insights into mechanism of how p53 stability is regulated and how p53 is induced in response to DNA damage. We also propose to screen for inhibitors of Mdm2-mediated p53 degradation using our in vitro degradation assay system. The identified protein(s) and the inhibitors can be potential candidate for the development of therapeutic agent to reactivate p53 activity in cancer cells.
The Specific Aims i nclude: 1) to identify the p53 determinant-interacting protein essential for Mdm2-mediated p53 degradation and to examine role of the p53 determinant in regulation of p53 nuclear import/export: 2) To investigate role of the protein in Mdm2-targeted p53 degradation and p53-induction in response to DNA damage: 3) to search for inhibitors of p53 degradation by screening small compounds using our in vitro degradation assay system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA085679-01A1
Application #
6286907
Study Section
Radiation Study Section (RAD)
Program Officer
Pelroy, Richard
Project Start
2001-06-15
Project End
2004-05-31
Budget Start
2001-06-15
Budget End
2002-05-31
Support Year
1
Fiscal Year
2001
Total Cost
$276,515
Indirect Cost
Name
Harvard University
Department
Genetics
Type
Schools of Public Health
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Kuser-Abali, Gamze; Gong, Lu; Yan, Jiawei et al. (2018) An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage. Proc Natl Acad Sci U S A 115:3452-3457
de Polo, Anna; Luo, Zhongling; Gerarduzzi, Casimiro et al. (2017) AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex. J Mol Cell Biol 9:154-165
de Polo, Anna; Vivekanandan, Varunika; Little, John B et al. (2016) MDMX under stress: the MDMX-MDM2 complex as stress signals hub. Transl Cancer Res 5:725-732
Liu, X-S; Liu, Z; Gerarduzzi, C et al. (2016) Somatic human ZBTB7A zinc finger mutations promote cancer progression. Oncogene 35:3071-8
Yang, M; Lewinska, M; Fan, X et al. (2016) PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis. Oncogene 35:5527-5538
Qi, Min; Ganapathy, Suthakar; Zeng, Weiqi et al. (2015) UXT, a novel MDMX-binding protein, promotes glycolysis by mitigating p53-mediated restriction of NF-?B activity. Oncotarget 6:17584-93
Liu, Xue-Song; Little, John B; Yuan, Zhi-Min (2015) Glycolytic metabolism influences global chromatin structure. Oncotarget 6:4214-25
Liu, Xue-Song; Genet, Matthew D; Haines, Jenna E et al. (2015) ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM. Mol Cancer Res 13:1206-17
Yang, M; Yuan, Z-M (2015) A novel role of PRR14 in the regulation of skeletal myogenesis. Cell Death Dis 6:e1734
Lall, R; Ganapathy, S; Yang, M et al. (2014) Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death Differ 21:836-44

Showing the most recent 10 out of 30 publications